Finch Therapeutics Group, Inc. (FNCH) Earnings Per Share, Basic USD/shares 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Finch Therapeutics Group, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
  • Finch Therapeutics Group, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -2.41 USD/shares, a 93.9% increase year-over-year.
  • Finch Therapeutics Group, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -9.81 USD/shares, a 91.1% increase year-over-year.
  • Finch Therapeutics Group, Inc. annual Earnings Per Share, Basic for 2023 was -46.6 USD/shares, a 35.4% increase from 2022.
  • Finch Therapeutics Group, Inc. annual Earnings Per Share, Basic for 2022 was -72.1 USD/shares, a 4773% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$10 -$2 +$36.80 +93.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$47 -$2 +$30.40 +95.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$77 -$2 +$23.90 +94.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$101 -$4 +$9.98 +69.7% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-11
Q1 2023 -$111 -$39 -$39 -7437% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$72 -$32 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$25 -$25 -11986% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$14 Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-11
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.